Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data

Morbidity and mortality after allogeneic hematopoietic cell transplantation (alloHCT) are still essentially affected by reactivation of cytomegalovirus (CMV). We evaluated 80 seropositive patients transplanted consecutively between March 2018 and March 2019 who received letermovir (LET) prophylaxis...

Descripción completa

Detalles Bibliográficos
Autores principales: Derigs, Patrick, Radujkovic, Aleksandar, Schubert, Maria-Luisa, Schnitzler, Paul, Schöning, Tilman, Müller-Tidow, Carsten, Hegenbart, Ute, Schönland, Stefan O., Luft, Thomas, Dreger, Peter, Schmitt, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285358/
https://www.ncbi.nlm.nih.gov/pubmed/33270162
http://dx.doi.org/10.1007/s00277-020-04362-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285358/
https://www.ncbi.nlm.nih.gov/pubmed/33270162
http://dx.doi.org/10.1007/s00277-020-04362-2

Ejemplares similares